Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
This helps quickly fix the problem and ease symptoms
Many report improved energy, reduced fatigue, better exercise capacity, and reduced carbohydrate cravings
Why Product Amounts Stay Outside Canonical Targeting Catalog amounts such as 50mg are product-listing specifications, not the canonical research entity
Making healthy red blood cells
Hydroxocobalamin is a powerful, long-acting form of vitamin B12 that plays a critical role in energy production, red blood cell formation, and nervous system function